Study of the Efficacy, Safety \& Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
1
Matching placebo
Study Site 404
Phoenix, Arizona, United States
Study Site 402
Washington D.C., District of Columbia, United States
Study Site 412
Gainesville, Florida, United States
Study Site 403
Tampa, Florida, United States
Change in Itch Intensity - Numeric Rating Scale
Time frame: Week 6
Itch Intensity Responder Rate - Numeric Rating Scale
Time frame: Week 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Study Site 409
Lincoln, Nebraska, United States
Study Site 401
Winston-Salem, North Carolina, United States
Study Site 413
Seattle, Washington, United States